PL425239A1 - Zastosowanie 2'-hydroksy-4-metylochalkonu - Google Patents

Zastosowanie 2'-hydroksy-4-metylochalkonu

Info

Publication number
PL425239A1
PL425239A1 PL425239A PL42523918A PL425239A1 PL 425239 A1 PL425239 A1 PL 425239A1 PL 425239 A PL425239 A PL 425239A PL 42523918 A PL42523918 A PL 42523918A PL 425239 A1 PL425239 A1 PL 425239A1
Authority
PL
Poland
Prior art keywords
methylchalcone
hydroxy
application
prevention
treatment
Prior art date
Application number
PL425239A
Other languages
English (en)
Other versions
PL238125B1 (pl
Inventor
Ewa Grela
Joanna Kozłowska
Mirosław Anioł
Agnieszka Grabowiecka
Bartłomiej Potaniec
Original Assignee
Uniwersytet Przyrodniczy we Wrocławiu
Politechnika Wrocławska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy we Wrocławiu, Politechnika Wrocławska filed Critical Uniwersytet Przyrodniczy we Wrocławiu
Priority to PL425239(22)20180416A priority Critical patent/PL238125B1/pl
Publication of PL425239A1 publication Critical patent/PL425239A1/pl
Publication of PL238125B1 publication Critical patent/PL238125B1/pl

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest zastosowanie 2'-hydroksy-4-metylochalkonu do wytwarzania leku i/lub jako składnika produktów leczniczych do leczenia i zapobiegania kamicy nerkowej, kamicy moczowodu oraz kamienia w obrębie dolnych dróg moczowych, jak również zapalenia pęcherza moczowego oraz do wytwarzania suplementów diety, środków żywieniowych lub jako składnika żywności funkcjonalnej, stosowanych wspomagająco w leczeniu i w profilaktyce tych chorób.
PL425239(22)20180416A 2018-04-16 2018-04-16 Zastosowanie 2’-hydroksy-4-metylochalkonu PL238125B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL425239(22)20180416A PL238125B1 (pl) 2018-04-16 2018-04-16 Zastosowanie 2’-hydroksy-4-metylochalkonu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL425239(22)20180416A PL238125B1 (pl) 2018-04-16 2018-04-16 Zastosowanie 2’-hydroksy-4-metylochalkonu

Publications (2)

Publication Number Publication Date
PL425239A1 true PL425239A1 (pl) 2019-10-21
PL238125B1 PL238125B1 (pl) 2021-07-05

Family

ID=68238640

Family Applications (1)

Application Number Title Priority Date Filing Date
PL425239(22)20180416A PL238125B1 (pl) 2018-04-16 2018-04-16 Zastosowanie 2’-hydroksy-4-metylochalkonu

Country Status (1)

Country Link
PL (1) PL238125B1 (pl)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GOODARZI M., BINARY C1ASSIFICATION OF CHALCONE DERIVATIVES WITH LDA OR KNN BASED ON THEIR ANTILEISHMANIAL ACTIVITY AND MOLECULAR DESCRIPTORS SELECTED USING THE SUCCESSIVE PROJECTIONS A1GORITHM FEATURE-SELECTION TECHNIQUE, 23 January 2014 (2014-01-23) *
M .V .KAVERI, SYNTHESIS AND SPECTRAI STUDIES OF RUCI CO L PPH3 B - HL=2-HYDROXYCHALCONES AND B = PPH3 PYRIDINE OR PIPERIDINE AND THEIR CATALYTIC AND BIOLOGICAL APPLICATIONS, 2005 *
MOSTAHAR S., CYTOTOXIC AND ANTIMICROBIAL ACTIVITIES OF SOME SYNTHETIC FLAVONES, 30 June 2006 (2006-06-30) *

Also Published As

Publication number Publication date
PL238125B1 (pl) 2021-07-05

Similar Documents

Publication Publication Date Title
NZ745678A (en) Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
MA33075B1 (fr) Composition destinee a la regulation du metabolism des lipides
AR106644A1 (es) Composiciones nutricionales sinergísticas y usos de las mismas
BR102013003570A8 (pt) Composições de plasma rico em plaquetas
BRPI0410267A (pt) composições contendo enzimas, produtos alimentares dietéticos e medicamentos produzidos das mesmas e sua utilização para fins medicinais
EP3318251A3 (en) Composition for preventing or treating obesity or lipid-related metabolic disease
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
BR112018076800A2 (pt) derivado de guanidina, medicamento, inibidor da proteína 1 da translocação de linfoma de tecido linfóide associado com mucosa, e, agente terapêutico ou profilático.
MY195760A (en) Use of IDHP in Preparation of Drug or Health Product for Prevention and Treatment of Coronary Atherosclerosis Disease
EP3766503A4 (en) USE OF A MICRORNA 210 INHIBITOR IN THE MANUFACTURING MEDICINAL PRODUCTS FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES
WO2019040459A3 (en) Composition and nutritional supplement made therefrom
PL425238A1 (pl) Zastosowanie 2'-hydroksy-4-etylochalkonu
PL425239A1 (pl) Zastosowanie 2'-hydroksy-4-metylochalkonu
CO2025007626A2 (es) Composiciones farmacéuticas para administración ocular
BR112019023944A2 (pt) combinação farmacêutica para o tratamento de um câncer
PL425240A1 (pl) Zastosowanie 7-aminoflawonu
PL425242A1 (pl) Zastosowanie 3'-amino-4-karboksychalkonu
CR8265A (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de enfermedades mediadas por cox-2
PL425241A1 (pl) Zastosowanie 2'-hydroksychalkonu
PL425235A1 (pl) Zastosowanie izoksantohumolu
MX2007004104A (es) Uso de aceite de lavanda para la profilaxis y el tratamiento de neurastenia, problemas de somatizacion y otras enfermedades asociadas con la tension.
JOP20220313A1 (ar) تركيبة دوائية مائية من الليفيليماب وإستخدامها
PL423329A1 (pl) Zastosowanie jagody kamczackiej Lonicera caerulea L. var. Kamtschatica lub jej tkanek lub ich wytworów, zwłaszcza ekstraktu z owoców
PL421363A1 (pl) Zastosowanie derenia właściwego Cornus mas L. lub jego tkanek lub ich wytworów, zwłaszcza ekstraktu z owoców
SG11201806628UA (en) New bi-aromatic propynyl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof